Virginia Lemme, PA
Physician Assistant · Sioux Falls, SDNPI 1346293610
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,809 of the $6,071 with a category attached, or 79.2%. 33 manufacturers reported payments, led by Pfizer at 24.6% of the total. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 298 payments — averaging $20.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- AbbVie$849
- Lilly USA, LLC$632
- Astellas Pharma US Inc$381
- Novo Nordisk$353
- Amgen$282
- plus $2K from 27 others
What the payments were for
- Consulting fees$1,08018%
- Food & beverage$4,80979%
- Education$1823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 36 | $1,496 |
| AbbVie | 50 | $849 |
| Lilly USA, LLC | 37 | $632 |
| Astellas Pharma US Inc | 18 | $381 |
| Novo Nordisk | 20 | $353 |
| Amgen | 17 | $282 |
| Phathom Pharmaceuticals, Inc. | 11 | $268 |
| Novartis | 13 | $226 |
| Boehringer Ingelheim | 12 | $203 |
| GSK | 10 | $177 |
| Otsuka America Pharmaceutical, Inc. | 9 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $129 |
| AstraZeneca | 8 | $110 |
| Daiichi Sankyo Inc. | 6 | $101 |
| Biohaven Pharmaceuticals, Inc. | 6 | $97 |
| Exact Sciences | 6 | $95 |
| Bayer | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $85 |
| Merck | 4 | $56 |
| Johnson & Johnson | 2 | $33 |
| Sandoz | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Corium, LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Radius Health, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Vistapharm, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,071 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $95,145 |
| EliquisApixaban | 75 | $65,708 |
| MounjaroTirzepatide | 63 | $65,637 |
| XareltoRivaroxaban | 40 | $36,657 |
| JardianceEmpagliflozin | 26 | $32,120 |
| TrulicityDulaglutide | 15 | $23,516 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $17,780 |
| Repatha SureclickEvolocumab | 24 | $16,854 |
| Praluent PenAlirocumab | 21 | $10,524 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $6,112 |
| Bupropion XlBupropion Hcl | 115 | $4,860 |
| Arnuity ElliptaFluticasone Furoate | 16 | $4,456 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $3,675 |
| Gabapentin | 257 | $3,615 |
| SynthroidLevothyroxine Sodium | 67 | $3,537 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $353 | $95,14573 claims |
| Lilly USA, LLCMounjaro, Trulicity | $632 | $89,15378 claims |
| PfizerEliquis | $1,496 | $65,70875 claims |
| Johnson & JohnsonXarelto | $33 | $36,65740 claims |
| Boehringer IngelheimJardiance | $203 | $32,12026 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $177 | $22,23736 claims |
| AbbVieSynthroid | $849 | $3,53767 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Sioux Falls
- Kimberly NelsonSioux Falls$11K
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Gabriel PenaredondoSioux Falls$7K
- Kathrine JibbenSioux Falls$6K
- Austen FagerlandSioux Falls$6K
- Cheryle BrandtSioux Falls$6K
- Rachelle BroveleitSioux Falls$5K
- Stephanie SteltonSioux Falls$5K
- Joseph NewmanSioux Falls$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.